300326 ST凯利
开盘竞价 03-13 09:30:00
资讯
新帖
简况
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，3月11日股价上涨2.54%
证券之星 · 03-11 22:26
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，3月11日股价上涨2.54%
ST凯利：相关交易已完成交割
证券之星 · 01-29
ST凯利：相关交易已完成交割
ST凯利：预计扭亏为盈将按规定进行业绩预告
证券之星 · 01-21
ST凯利：预计扭亏为盈将按规定进行业绩预告
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，1月19日股价上涨0.52%
证券之星 · 01-19
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，1月19日股价上涨0.52%
ST凯利（300326）披露出售洁诺医疗股权及退出景正医疗进展公告，1月14日股价上涨1.41%
证券之星 · 01-14
ST凯利（300326）披露出售洁诺医疗股权及退出景正医疗进展公告，1月14日股价上涨1.41%
股市必读：ST凯利（300326）1月9日董秘有最新回复
证券之星 · 01-12
股市必读：ST凯利（300326）1月9日董秘有最新回复
ST凯利（300326）2名股东合计质押4559.42万股，占总股本6.36%
证券之星 · 01-06
ST凯利（300326）2名股东合计质押4559.42万股，占总股本6.36%
ST凯利（300326）披露持股5%以上股东股份解除质押公告，12月25日股价上涨0.18%
证券之星 · 2025-12-25
ST凯利（300326）披露持股5%以上股东股份解除质押公告，12月25日股价上涨0.18%
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，12月19日股价上涨0.73%
证券之星 · 2025-12-19
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，12月19日股价上涨0.73%
ST凯利：出售洁诺医疗股权及转让利格泰股权正按协议履行
证券之星 · 2025-12-15
ST凯利：出售洁诺医疗股权及转让利格泰股权正按协议履行
ST凯利：满足条件后将申请摘帽
证券之星 · 2025-12-15
ST凯利：满足条件后将申请摘帽
ST凯利（300326）披露关于上海证监局行政监管措施决定书相关问题的整改报告，11月27日股价上涨0.7%
证券之星 · 2025-11-27
ST凯利（300326）披露关于上海证监局行政监管措施决定书相关问题的整改报告，11月27日股价上涨0.7%
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，11月21日股价下跌4.07%
证券之星 · 2025-11-21
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，11月21日股价下跌4.07%
ST凯利(300326.SZ)拟将对动之医学持股比例提高至50.9014% 其主营再生诱导系列产品
智通财经 · 2025-11-21
ST凯利(300326.SZ)拟将对动之医学持股比例提高至50.9014% 其主营再生诱导系列产品
ST凯利：2024年国外市场营收占比22.26%
证券之星 · 2025-11-13
ST凯利：2024年国外市场营收占比22.26%
ST凯利：公司违规行为不会触发退市风险警示
证券之星 · 2025-11-03
ST凯利：公司违规行为不会触发退市风险警示
ST凯利因未及时披露公司重大事件等违规行为被证监会责令改正
证券之星 · 2025-10-29
ST凯利因未及时披露公司重大事件等违规行为被证监会责令改正
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，10月23日股价下跌0.5%
证券之星 · 2025-10-23
ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，10月23日股价下跌0.5%
ST凯利第三季度营收降11.8%至2.42亿元 净利润增6.3%
财中社 · 2025-10-22
ST凯利第三季度营收降11.8%至2.42亿元 净利润增6.3%
股市必读：ST凯利（300326）10月21日董秘有最新回复
证券之星 · 2025-10-22
股市必读：ST凯利（300326）10月21日董秘有最新回复
公司概况
公司名称：
上海凯利泰医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2012-06-13
主营业务：
上海凯利泰医疗科技股份有限公司的主营业务是骨科植入医疗器械的生产、研发、销售及服务。公司的主要产品是脊柱微创类产品、骨科创伤类植入器械产品等。
发行价格：
29.09
{"stockData":{"symbol":"300326","market":"SZ","secType":"STK","nameCN":"ST凯利","latestPrice":6.2,"timestamp":1773364953000,"preClose":6.24,"halted":0,"volume":0,"delay":0,"changeRate":-0.0064,"floatShares":710000000,"shares":717000000,"eps":-0.1261,"marketStatus":"开盘竞价","change":-0.04,"latestTime":"03-13 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":6.2,"askSize":422,"bidPrice":6.2,"bidSize":422,"shortable":0,"etf":0,"ttmEps":-0.1261,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773365400000},"marketStatusCode":1,"adr":0,"adjPreClose":6.24,"symbolType":"stock","openAndCloseTimeList":[[1773365400000,1773372600000],[1773378000000,1773385200000]],"highLimit":6.55,"lowLimit":5.93,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":717012682,"isCdr":false,"pbRate":1.61,"roa":"--","roe":"2.59%","epsLYR":-0.1472,"committee":-0.178988,"marketValue":4445000000,"turnoverRate":0,"status":1,"floatMarketCap":4403000000},"requestUrl":"/m/hq/s/300326/wiki","defaultTab":"wiki","newsList":[{"id":"2618692563","title":"ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，3月11日股价上涨2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618692563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618692563?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:26","pubTimestamp":1773239179,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，ST凯利报收于6.47元，较前一交易日上涨2.54%，最新总市值为46.39亿元。该股当日开盘6.31元，最高6.47元，最低6.3元，成交额达6192.22万元，换手率为1.36%。近日，ST凯利发布《关于公司股票被实施其他风险警示相关事项的进展公告》。公告显示，公司因2024年度财务报告内部控制被会计师事务所出具无法表示意见的审计报告，股票交易被实施其他风险警示。公司将按月披露进展，直至相关情形消除。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2607108276","title":"ST凯利：相关交易已完成交割","url":"https://stock-news.laohu8.com/highlight/detail?id=2607108276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607108276?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:48","pubTimestamp":1769690897,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利(300326)01月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司出让上海利格泰生物科技股份有限公司7.0130%股权的利润是否算在25年年报里了.ST凯利回复：您好，感谢您对公司的关注与支持，公司已于2026年1月23日披露了《关于转让公司持有的上海利格泰生物科技股份有限公司股份暨关联交易的进展公告》（公告编号：2026-007），相关交易已完成交割，相关投资收益将按照企业会计准则的规定进行相应的财务处理，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900040701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2605026811","title":"ST凯利：预计扭亏为盈将按规定进行业绩预告","url":"https://stock-news.laohu8.com/highlight/detail?id=2605026811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605026811?lang=zh_cn&edition=full","pubTime":"2026-01-21 20:51","pubTimestamp":1768999886,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利01月20日在投资者关系平台上答复投资者关心的问题。投资者提问：您好董秘，如果凯利泰预计能在2025年实现扭亏为盈，是否属于创业板强制披露年报预告的情形，必须在 2026 年 1 月 31 日前发布年报预告，无豁免空间。公司信息披露事宜会根据公司情况结合《深圳证券交易所股票上市规则》等相关法律法规的要求履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100038894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2604131405","title":"ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，1月19日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604131405","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604131405?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:47","pubTimestamp":1768834032,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，ST凯利报收于5.76元，较前一交易日上涨0.52%，最新总市值为41.3亿元。该股当日开盘5.73元，最高5.77元，最低5.7元，成交额达2789.39万元，换手率为0.68%。同日，ST凯利发布关于公司股票被实施其他风险警示相关事项的进展公告。公告显示，公司因2024年度财务报告内部控制被会计师事务所出具无法表示意见的审计报告，股票交易被实施其他风险警示。公司将持续推动整改措施落实，确保定期报告编制规范有序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2603612443","title":"ST凯利（300326）披露出售洁诺医疗股权及退出景正医疗进展公告，1月14日股价上涨1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603612443?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:41","pubTimestamp":1768401670,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，ST凯利报收于5.77元，较前一交易日上涨1.41%，最新总市值为41.37亿元。该股当日开盘5.68元，最高5.79元，最低5.66元，成交额达6009.73万元，换手率为1.47%。公司近日发布公告称，关于出售通过景正医疗间接持有的洁诺医疗管理集团有限公司36.9000%股权并减资退出上海景正医疗科技有限公司的事项已取得进展。截至2026年1月14日，相关股权转让及减资协议已签署，工商变更登记已完成，公司已收到全部款项，交易交割完毕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","BK0251","300326"],"gpt_icon":0},{"id":"2602557193","title":"股市必读：ST凯利（300326）1月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2602557193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602557193?lang=zh_cn&edition=full","pubTime":"2026-01-12 02:36","pubTimestamp":1768156571,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，ST凯利报收于5.66元，上涨0.0%，换手率0.81%，成交量5.79万手，成交额3276.09万元。董秘最新回复投资者： 2026年，尊敬的董秘，按约定，转让款到账了没？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200001041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2601896622","title":"ST凯利（300326）2名股东合计质押4559.42万股，占总股本6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601896622","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601896622?lang=zh_cn&edition=full","pubTime":"2026-01-06 18:38","pubTimestamp":1767695886,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利1月6日公开信息显示，股东上海欣诚意投资有限公司、袁征向上海银行股份有限公司浦东分行合计质押4559.42万股，占总股本6.36%。质押详情见下表：截止本公告日，股东上海欣诚意投资有限公司已累计质押股份3696.81万股，占其持股总数的100.0%，股东袁征已累计质押股份862.61万股，占其持股总数的100.0%。ST凯利主营业务：骨科植入医疗器械的生产、研发、销售及服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600033068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2594230522","title":"ST凯利（300326）披露持股5%以上股东股份解除质押公告，12月25日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594230522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594230522?lang=zh_cn&edition=full","pubTime":"2025-12-25 23:03","pubTimestamp":1766675003,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，ST凯利报收于5.67元，较前一交易日上涨0.18%，最新总市值为40.65亿元。该股当日开盘5.66元，最高5.69元，最低5.63元，成交额达1421.94万元，换手率为0.35%。公司近日发布公告称，持股5%以上股东上海欣诚意投资有限公司将其所持有的36,000,000股公司股份解除质押，占其所持股份比例97.28%，占公司总股本比例5.02%。质押起始日为2025年6月19日，解除日为2025年12月23日，质权人为上海星富德企业管理合伙企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2592919842","title":"ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，12月19日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592919842","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592919842?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:43","pubTimestamp":1766155400,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，ST凯利报收于5.53元，较前一交易日上涨0.73%，最新总市值为39.65亿元。同日，ST凯利发布关于公司股票被实施其他风险警示相关事项的进展公告。公告显示，公司因2024年度财务报告内部控制被会计师事务所出具无法表示意见的审计报告，股票交易被实施其他风险警示。同时，公司进一步加强关联交易管理，前移识别关口，积极与监管部门沟通，落实整改要求，提升合规水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326","BK0251"],"gpt_icon":0},{"id":"2591649840","title":"ST凯利：出售洁诺医疗股权及转让利格泰股权正按协议履行","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649840","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649840?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:51","pubTimestamp":1765803085,"startTime":"0","endTime":"0","summary":"ST凯利回复：您好，感谢您对公司的关注与支持，目前公司出售洁诺医疗股权并减资退出上海景正医疗以及公司转让上海利格泰生物科技公司的股权的相关交易正按照协议约定正常履行，未来公司将根据交易完成情况按照现行法律法规要求披露相关进展公告；股东上海凯诚君泰及其一致行动人未来如有相关增持事项，将按照相关法律法规及有关规定的要求及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500032256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326","159891"],"gpt_icon":0},{"id":"2591649822","title":"ST凯利：满足条件后将申请摘帽","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649822?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:51","pubTimestamp":1765803084,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利12月15日在投资者关系平台上答复投资者关心的问题。公司拟申请撤销其他风险警示的，应当在披露之日起五个交易日内向深圳证券交易所提交申请。公司将在满足上述条件后及时提出申请，争取尽早撤销风险警示。有关公司信息敬请以公司在指定媒体披露的信息为准，请投资者关注公司公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500032254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2586175225","title":"ST凯利（300326）披露关于上海证监局行政监管措施决定书相关问题的整改报告，11月27日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586175225","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586175225?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:27","pubTimestamp":1764253639,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，ST凯利报收于5.79元，较前一交易日上涨0.7%，最新总市值为41.52亿元。公司于近日披露了《关于上海证监局行政监管措施决定书相关问题的整改报告》。公告显示，上海凯利泰医疗科技股份有限公司因前任总经理王正民未上报其关联自然人郑雯，导致公司未及时披露2020年至2023年与郑雯持股的正佰芮公司之间的关联交易。公司已采取修订关联交易制度、加强培训、完善内控机制等整改措施，并将补充履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326","BK0251"],"gpt_icon":0},{"id":"2585141845","title":"ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，11月21日股价下跌4.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141845?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:38","pubTimestamp":1763735933,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，ST凯利报收于5.65元，较前一交易日下跌4.07%，最新总市值为40.51亿元。该股当日开盘5.85元，最高5.96元，最低5.64元，成交额达6413.63万元，换手率为1.57%。同日，ST凯利发布《关于公司股票被实施其他风险警示相关事项的进展公告》。公告显示，公司因2024年度财务报告内部控制被会计师事务所出具无法表示意见的审计报告，股票交易被实施其他风险警示。公司将每月披露相关进展公告，直至相关情形消除。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326","BK0251"],"gpt_icon":0},{"id":"2585115235","title":"ST凯利(300326.SZ)拟将对动之医学持股比例提高至50.9014% 其主营再生诱导系列产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2585115235","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585115235?lang=zh_cn&edition=full","pubTime":"2025-11-21 17:16","pubTimestamp":1763716575,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ST凯利 公告，公司拟通过受让股权并认购新增注册资本的方式对动之医学技术(上海)有限公司进行投资。公告显示，动之医学是一家致力于研发、生产和销售再生诱导系列产品的企业，其注册资本为178.3679万元。上述交易完成后，公司对动之医学的持股比例从37.9528%增加至50.9014%。据悉，动之医学的生物补片产品提高了公司在研发及生产再生诱导系列产品领域的竞争力，目前产品已经完成上市前临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ST凯利(300326.SZ)拟将对动之医学持股比例提高至50.9014% 其主营再生诱导系列产品","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2583609705","title":"ST凯利：2024年国外市场营收占比22.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583609705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583609705?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:51","pubTimestamp":1763038311,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利11月12日在投资者关系平台上答复投资者关心的问题。出口海外产品毛利率是多少ST凯利回复：您好，感谢您对公司的关注与支持。根据公司2024年度报告，公司2024年度国外市场营业收入为219,114,693.56元，占2024年度总营业收入的比例为22.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300039908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326"],"gpt_icon":0},{"id":"2580221824","title":"ST凯利：公司违规行为不会触发退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2580221824","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580221824?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:51","pubTimestamp":1762174282,"startTime":"0","endTime":"0","summary":"证券之星消息，ST凯利11月03日在投资者关系平台上答复投资者关心的问题。同时，袁征、王正民、丁魁作为公司时任主要管理人员，未能恪尽职守、履行诚信勤勉义务，其行为违反了《创业板股票上市规则》第1.4条、第5.1.2条的规定，对公司上述违规行为负有责任。贵公司是否存在退市风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300033321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2579522967","title":"ST凯利因未及时披露公司重大事件等违规行为被证监会责令改正","url":"https://stock-news.laohu8.com/highlight/detail?id=2579522967","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579522967?lang=zh_cn&edition=full","pubTime":"2025-10-29 01:00","pubTimestamp":1761670850,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日ST凯利公开信息显示，上海凯利泰医疗科技股份有限公司，总经理丁魁、袁征、王正民因未及时披露公司重大事件,未依法履行其他职责,信息披露违规被中国证券监督管理委员会上海监管局责令改正。对凯利泰采取责令改正的行政监管措施。公司应采取有效措施进行改正,并于收到本决定书之日起30日内向我局提交书面整改报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900001962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326","BK0251"],"gpt_icon":0},{"id":"2577837955","title":"ST凯利（300326）披露公司股票被实施其他风险警示相关事项的进展公告，10月23日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577837955","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577837955?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:30","pubTimestamp":1761229835,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，ST凯利报收于5.92元，较前一交易日下跌0.5%，最新总市值为42.45亿元。公告显示，公司因2024年度财务报告内部控制被会计师事务所出具无法表示意见的审计报告，根据《创业板股票上市规则》相关规定，公司股票交易被实施其他风险警示，并需披露可能被实施退市风险警示的风险提示公告。公司将在股票被实施其他风险警示期间，至少每月披露一次进展公告，直至相关情形消除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300326"],"gpt_icon":0},{"id":"2577648903","title":"ST凯利第三季度营收降11.8%至2.42亿元 净利润增6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577648903","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577648903?lang=zh_cn&edition=full","pubTime":"2025-10-22 19:48","pubTimestamp":1761133680,"startTime":"0","endTime":"0","summary":" 其中第三季度，公司营业收入为2.42亿元，同比下降11.8%；归母净利润为2744万元，同比上升6.3%；扣非归母净利润为1835万元，同比下降4.5%；EPS为0.0383元。 截至三季度末，公司总资产33.78亿元，较上年度末增长0.8%；归母净资产为27.87亿元，较上年度末增长2.4%。 公司在2025年第三季度报告中介绍了其业务及相关情况。 在报告中，公司指出其各项业务运营情况良好，尤其是在创新产品的研发和市场推广方面取得了积极进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-22/doc-infuuprm0295217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300326"],"gpt_icon":0},{"id":"2577769802","title":"股市必读：ST凯利（300326）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577769802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577769802?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:35","pubTimestamp":1761078910,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，ST凯利报收于5.95元，上涨2.59%，换手率0.95%，成交量6.8万手，成交额4017.51万元。董秘最新回复投资者： 贵公司是否有产品适用于医美？交易信息汇总资金流向10月21日主力资金净流出49.15万元；游资资金净流入312.71万元；散户资金净流出263.55万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300326","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773364966706,"stockEarnings":[{"period":"1week","weight":0.0179},{"period":"1month","weight":0.0048},{"period":"3month","weight":0.1345},{"period":"6month","weight":0.0986},{"period":"1year","weight":-0.2031},{"period":"ytd","weight":0.0986}],"compareEarnings":[{"period":"1week","weight":0.005},{"period":"1month","weight":0.0002},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.0668},{"period":"1year","weight":0.2246},{"period":"ytd","weight":0.0404}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯利泰医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"34020人(较上一季度减少10.41%)","perCapita":"20873股","listingDate":"2012-06-13","address":"上海市浦东新区张江高科技园东区瑞庆路528号23幢","registeredCapital":"71701万元","survey":" 上海凯利泰医疗科技股份有限公司的主营业务是骨科植入医疗器械的生产、研发、销售及服务。公司的主要产品是脊柱微创类产品、骨科创伤类植入器械产品等。","listedPrice":29.09},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST凯利(300326)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST凯利(300326)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST凯利,300326,ST凯利股票,ST凯利股票老虎,ST凯利股票老虎国际,ST凯利行情,ST凯利股票行情,ST凯利股价,ST凯利股市,ST凯利股票价格,ST凯利股票交易,ST凯利股票购买,ST凯利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST凯利(300326)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST凯利(300326)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}